Clinical Trials Browser

Phase 2 × Completed × navitoclax × Clear all

NCT02591095 2019-03-19

MONAVI-1

Phase 2 Completed

Ovarian Neoplasms

NCT01087151 2016-11-02

A Study of ABT-263 in Combination With Dose-Intensive Rituximab, or Dose-Intensive Rituximab Alone, in Previously Untreated Patients With B-Cell, Chronic Lymphocytic Leukemia (CLL)

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell